Wednesday, 24 May 2023

Postpartum Haemorrhage (PPH) & Role of Carbetocin: An Advanced Novel Therapy | Chapter 11 | Novel Aspects on Pharmaceutical Research Vol. 2

 To prevent postpartum haemorrhage (PPH), the routine presidency of a uterotonic agent like oxytocin is standard practice. Failure of precaution with oxytocin happens commonly, necessitating the use of further oxytocin or additional treatments to uphold haemodynamic stability. Oxytocin has allure limitations as it demands cold storage and transport, and in low-capital settings, the cold chain is not usually available. By changing the oxytocin molecule, allure half-life has been extended and its concerned with atom and molecule change degradation weakened. The modified particle is named carbetocin. Heat-stable carbetocin is a hopeful alternative to oxytocin, which can overcome the determined problems accompanying oxytocin quality as it does not demand a cold chain for storage and transport.

Author(s) Details:

Amit Bhalla,
Department of Medical Affairs, Uniza Healthcare LLP, Ahmedabad, Gujarat, India.

Please see the link here: https://stm.bookpi.org/NAPR-V2/article/view/10604

No comments:

Post a Comment